PlainRecalls
FDA Drug Moderate Class II Terminated

allergyrelief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)30-count cartons (NDC 56062-847-39); and b) 45-count cartons (NDC 56062-847-95), Distributed by: Publix Super Markets, Inc., 3300 Publix Corporate Parkway, Lakeland, FL 33811.

Reported: July 19, 2023 Initiated: February 9, 2023 #D-0909-2023

Product Description

allergyrelief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)30-count cartons (NDC 56062-847-39); and b) 45-count cartons (NDC 56062-847-95), Distributed by: Publix Super Markets, Inc., 3300 Publix Corporate Parkway, Lakeland, FL 33811.

Reason for Recall

Failed Impurities/Degradation Specifications

Details

Recalling Firm
L. Perrigo Company
Units Affected
32,904 cartons
Distribution
Nationwide within the USA
Location
Allegan, MI

Frequently Asked Questions

What product was recalled?
allergyrelief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)30-count cartons (NDC 56062-847-39); and b) 45-count cartons (NDC 56062-847-95), Distributed by: Publix Super Markets, Inc., 3300 Publix Corporate Parkway, Lakeland, FL 33811.. Recalled by L. Perrigo Company. Units affected: 32,904 cartons.
Why was this product recalled?
Failed Impurities/Degradation Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on July 19, 2023. Severity: Moderate. Recall number: D-0909-2023.